A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
Clinical trial NCT03108729 · WITHDRAWN
Trial details
- NCT number
- NCT03108729
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-06
- Primary completion
- 2017-10-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.